Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Profit RMB36 Mln
08/04/2022 15:38
April 8 (Reuters) - Shenzhen Neptunus Interlong
Bio-technique Co Ltd 8329.HK :
* FY PROFIT & TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE RMB36
MILLION VERSUS RMB36.6 MILLION
* FY REVENUE RMB838.8 MILLION VERSUS RMB1.03 BILLION
Source text for Eikon: ID:nHKS7fLVSz
Further company coverage: 8329.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million